Algernon Pharmaceuticals finding new uses for safe, older drugs
Algernon Pharmaceuticals Inc (OTCMKTS:BTHCF) CEO Christoper Moreau …
Repurposed Anti-fibrotic Medication, NP-120, Set for Phase 2 Testing for IPF
by Joana Carvalho on August 2nd, 2019 Algernon, a pharmaceutical …
Vancouver company repurposes Soviet Union doping drug to cure kidney disease
by Kate Wilson on August 1st, 2019 Today, Algernon announced that …